Group has adopted the new Thai Financial Reporting Standards (TFRS) no. 15, Revenue from contracts with customer. The adoption of TFRS 15 mainly affects the Group’s accounting treatment cause the Group
which posted 26% growth yoy due to more intensity treatment, epidemics and weather change in the beginning of this year as well as increasing number of beds in service. Cost of Hospital Operations Cost of
% Medical treatment 478.45 442.26 36.19 8.18 Medical service 24.70 16.18 8.53 52.70 Drugs and medical supplies 0.86 0.98 (0.12) (12.27) Other supplies 1.14 1.35 (0.22) (15.92) X-ray 11.30 10.09 1.21 11.97
Increase (Decrease) Amount % Medical treatment 104.71 111.67 (6.96) (6.24) Medical service 7.01 4.65 2.36 50.77 Drugs and medical supplies 0.18 0.21 (0.02) (11.02) Other supplies 0.22 0.17 0.05 30.82 X-ray
Baht 90 million, and waste water treatment services of Baht 23 million. Revenue (9 months) Overall, quarter 3/2020, the Company had sales and service income of Baht 828.81 million, which increased from
operating under remedy period. AIS has fully operated on the license base from 3Q16 onward. Following that, regulatory fee to service revenue dropped from 7.9% (excluding one-time USO fee) in 1Q16 to 5.8% in
exchange for the Baht 134.71 million remedy. 2.3 Cost of sale and rendering of services (excluding fuel costs) Cost of sale and rendering of services for the year 2017 was Baht 5,503.11 million (excluding
REIT manager; (3) the correction or other measures which are beneficial to the investors to amend, remedy or prevent the re-occurrence of the same demeanors; (4) other demeanors of the REIT manager which
public or any specific person; (4) any step taken thereafter to rectify, remedy or prevention of recurrence of similar facts or behaviors; (5) level of cooperation of the auditor with the SEC Office or any
. II) The rights and equitable treatment of shareholders and key ownership functions; The chapter identifies basic shareholder rights, including the right to information and participation through the